Silk Road Medical Inc
NASDAQ:SILK

Watchlist Manager
Silk Road Medical Inc Logo
Silk Road Medical Inc
NASDAQ:SILK
Watchlist
Price: 27.49 USD Market Closed
Market Cap: $1.1B

Net Margin

-29.5%
Current
Improving
by 3.4%
vs 3-y average of -33%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-29.5%
=
Net Income
$-56.5m
/
Revenue
$191.4m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-29.5%
=
Net Income
$-56.5m
/
Revenue
$191.4m

Peer Comparison

Country Company Market Cap Net
Margin
US
Silk Road Medical Inc
NASDAQ:SILK
1.1B USD
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.7B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.4B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
121.2B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
KR
HLB Inc
KOSDAQ:028300
8.7T KRW
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.4B CHF
Loading...

Market Distribution

Lower than 77% of companies in the United States of America
Percentile
23nd
Based on 15 072 companies
23nd percentile
-29.5%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Silk Road Medical Inc
Glance View

Market Cap
1.1B USD
Industry
Health Care

In the often complex maze of the medical device industry, Silk Road Medical Inc. has carved a distinctive path by addressing a significant healthcare need—reducing the risks associated with carotid artery disease, a major cause of stroke. Founded with a vision of minimizing the invasiveness of medical procedures, this California-based company has innovated a novel approach known as Transcarotid Artery Revascularization (TCAR). Unlike traditional methods, TCAR allows physicians to directly access the carotid artery through a small incision at the neckline. By temporarily reversing blood flow, it prevents any dislodged plaque from traveling to the brain during the procedure. This surgery can be completed in a fraction of the time typically required, providing a crucial advantage in terms of patient safety and recovery. Silk Road Medical's business model thrives on the production and sale of the specialized instruments that enable this innovative procedure. The company generates revenue primarily through the sale of these proprietary devices, which are designed to be used in conjunction with TCAR surgeries conducted by trained vascular surgeons. Their product line, which includes devices like the ENROUTE Transcarotid Neuroprotection System and the ENROUTE Transcarotid Stent System, is at the heart of their financial success. By offering a solution that blends safety, efficacy, and hospital efficiency, Silk Road Medical not only meets a medical demand but also strategically positions itself in a niche market, capitalizing on the growing adoption of minimally invasive techniques across healthcare systems worldwide.

SILK Intrinsic Value
20.84 USD
Overvaluation 24%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-29.5%
=
Net Income
$-56.5m
/
Revenue
$191.4m
What is Silk Road Medical Inc's current Net Margin?

The current Net Margin for Silk Road Medical Inc is -29.5%, which is above its 3-year median of -33%.

How has Net Margin changed over time?

Over the last 3 years, Silk Road Medical Inc’s Net Margin has increased from -53.9% to -29.5%. During this period, it reached a low of -55% on Sep 30, 2021 and a high of -28.8% on Mar 31, 2024.

Back to Top